Page 119 - Minutes of meeting
P. 119

The Resilience Challenge

 Innovation


 A study commissioned by Innovate UK reveals that historically, the   Expenditure on R&D by sector of performance (£ million), 2017
 amount of IUK funding accessed by North West organisations
 (5.8%) is proportionally less than the region’s business base (9.7%)   Cumbria  North   England
 and private sector R&D investment (11.8%). The North West could   West
 have benefited from an additional £86 million in public funding over   Business  £141  £2,174  £21,469
 the past ten years, if the funding secured was on par the region’s

 business base.  Government            -                  £216*            £1,994

 With respect to Cumbria, the study notes that the LEP ranks second   Higher Education  £1  £691  £6,666

 to last out of all LEPs in England, both in terms of the proportion of   Private Non Profit  -  £42*  £712
 IUK funding received and the total award value per business
 population. Cumbria’s top funded sectors include parts of the   Total  £165  £3,040  £30,841
 manufacturing sector, scientific research & development and office   * Combined figures for North West and North East due to confidentiality disclosure.
 administrative, office support & other business support activities.
       Patents granted

 Consistently with the study’s observations, expenditure on R&D
 amounted to £165 million in Cumbria in 2017, which accounts for
 only 5% of R&D spent across the North West. Most of that spending

 stemmed from the private sector (85%). The share of private sector
 expenditure exceeds that observed across the North West (72%)
 and England (70%).


 Looking at patents data, innovation activity levels in Barrow appear
 low. Generally, Barrow accounted for a small share of patents
 granted in Cumbria since 2000. However, Barrow’s share peaks in
 2008, which is surprising given the supressed levels of innovative
 activity between 2008 and 2010 across England.

 Source: Planning for a step change, Hatch Regeneris, 2018; Expenditure on R&D, ONS, 2019; Patent data, IPO, 2018
   114   115   116   117   118   119   120   121   122   123   124